Abstract
Histoplasmosis is one of the most frequent causes of fungal respiratory infection in endemic regions, has a broad spectrum of clinical manifestations and can present in several forms. The extent of disease is determined by the number of conidia inhaled, the immune response of the host and the integrity of the respiratory tract. From an initial and most benign form, acute pulmonary histoplasmosis (an influenza-like illness that is typically asymptomatic or mild in persons without prior immune compromise), histoplasmosis can become a lifethreatening progressive disseminated infection (PDH) that affects mainly immunocompromised patients, with high morbidity and mortality. Chronic pulmonary histoplasmosis is an uncommon manifestation of Histoplasma infection, with features similar to pulmonary tuberculosis, and if it remains undiagnosed or untreated it also can cause significant morbidity. Some rare but serious complications may also occur that are produced by an excessive immune response, such as mediastinal fibrosis, histoplasmoma and broncholithiasis. Histoplasmosis is highly endemic in regions of North, Central and South America as well as being reported in parts of Asia and Africa. The risk of histoplasmosis is greatest in patients with HIV infection, especially those with CD4+ counts of <200 cells/μL. We review clinical manifestations, radiological findings and treatment options according to the clinical form (induction therapy and maintenance therapy), as well as different diagnosis tools and new laboratory tests that have been recently developed and validated and are becoming widely available. These should have an impact in reducing time for diagnosis and starting therapy and in reducing morbidity and mortality, especially in patients with HIV infection, where histoplasmosis is currently estimated to be responsible for 5-15% of AIDS-related deaths.
Similar content being viewed by others
References
Deepe GS Jr. Histoplasma capsulatum. In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, douglas and bennett´s principles and practice of infectious diseases. 9th ed. Philadelphia, USA: Elsevier; 2020. p. 3162–76.
Thompson GR, Gómez BL. Histoplasma, Blastomyces, Coccidioides, and other dimorphic fungi causing systemic mycoses. In: Patel R, Ritcher SS, Warnock D, editors. Manually of Clinical Microbiology. Washington DC: ASM press; 2019.
World Health Organization/Pan American Health Organization. Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV. April 2020 https://iris.paho.org/handle/10665.2/52304
Adenis AA, Valdes A, Cropet C, McCotter OZ, Derado G, Couppie P, Chiller T, Nacher M. Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study. Lancet Infect Dis. 2018;18(10):1150–9.
Baker J, Kosmidis C, Rozaliyani A, Wahyuningsih R, Denning DW. Chronic pulmonary histoplasmosis-a scoping literature review. Open Forum Infect Dis. 2020;7(5):ofaa119. https://doi.org/10.1093/ofid/ofaa119.
Neglected histoplasmosis in Latin America Group Jan Disseminated histoplasmosis in Central and South America, the invisible elephant: the lethal blind spot of international health organizations AIDS 2016. https://doi.org/10.1097/QAD.0000000000000961.
Bahr NC, Antinori S, Wheat LJ, Sarosi GA. Histoplasmosis infections worldwide: thinking outside of the Ohio River valley. Curr Trop Med Rep. 2015;2(2):70–80. https://doi.org/10.1007/s40475-015-0044-0.PMID:26279969;PMCID:PMC4535725.
Newman SL. Macrophages in host defense against Histoplasma capsulatum. Trends Microbiol. 1999;7(2):67–71. https://doi.org/10.1016/s0966-842x(98)01431-0.
Kasuga T, White TJ, Koenig G, McEwen J, Restrepo A, Castañeda E, Da Silva LC, Heins-Vaccari EM, De Freitas RS, Zancopé-Oliveira RM, Qin Z, Negroni R, Carter DA, Mikami Y, Tamura M, Taylor ML, Miller GF, Poonwan N, Taylor JW. Phylogeography of the fungal pathogen Histoplasma capsulatum. Mol Ecol. 2003;12(12):3383–401. https://doi.org/10.1046/j.1365-294x.2003.01995.x.
de Teixeira MM, Patané JS, Taylor ML, Gómez BL, Theodoro RC, de Hoog S, Engelthaler DM, Zancopé-Oliveira RM, Felipe MS, Barker BM. Worldwide phylogenetic distributions and population dynamics of the genus histoplasma. PLoS Negl Trop Dis. 2016. https://doi.org/10.1371/journal.pntd.0004732.
Limper AH, Adenis A, Le T, Harrison TS. Fungal infections in HIV/AIDS. Lancet Infect Dis. 2017;17(11):e334–43. https://doi.org/10.1016/S1473-3099(17)30303-1.
Horwath MC, Fecher RA, Deepe GS Jr. Histoplasma capsulatum, lung infection and immunity. Future Microbiol. 2015;10(6):967–75.
Qing G, Yang S, Li Q, Zhang LL, Yuan GD, Chen SY, Lü SX, Huang GC, Chen Y, Wang X, Guo SL, Yan XF. Clinical and imaging features of acute histoplasmosis. Zhonghua Yi Xue Za Zhi. 2019;99(46):3603–7.
Gómez LF, Pérez LC, McEwen JG, Zuluaga A, Peláez CA, Acevedo JM, Taylor ML, Arango M, JiménezArteaga MD. Capacity of histoplasma capsulatum to survive the composting process. Applied and Environmental Soil Science. 2019. https://doi.org/10.1155/2019/5038153.
Benedict K, Mody RK. Epidemiology of Histoplasmosis Outbreaks, United States, 1938–2013. Emerg Infect Dis. 2016;22(3):370–8. https://doi.org/10.3201/eid2203.151117.
Wheat LJ, Wass J, Norton J, Kohler RB, French ML. Cavitary histoplasmosis occurring during two large urban outbreaks Analysis of clinical, epidemiologic, roentgenographic, and laboratory features. Medicine (Baltimore). 1984. https://doi.org/10.1097/00005792-198407000-00002.
Starnes SL, Reed MF, Meyer CA, Shipley RT, Jazieh AR, Pina EM, Redmond K, Huffman LC, Pandalai PK, Howington JA. Can lung cancer screening by computed tomography be effective in areas with endemic histoplasmosis? J Thorac Cardiovasc Surg. 2011;141(3):688–93. https://doi.org/10.1016/j.jtcvs.2010.08.045.
Oladele RO, Ayanlowo OO, Richardson MD, Denning DW. Histoplasmosis in Africa: an merging or a neglected disease? PLoS Negl Trop Dis. 2018;12(1): e0006046. https://doi.org/10.1371/journal.pntd.0006046.
Salzer HJF, Burchard G, Cornely OA, Lange C, Rolling T, Schmiedel S, Libman M, Capone D, Le T, Dalcolmo MP, Heyckendorf J. Diagnos and management of systemic endemic mycoses causing pulmonary disease. Respiration. 2018;96(3):283–301. https://doi.org/10.1159/000489501.
Albers EL, Pugh ME, Hill KD, Wang L, Loyd JE, Doyle TP. Percutaneous vascular stent implantation as treatment for central vascular obstruction due to fibrosing mediastinitis. Circulation. 2011;123(13):1391–9. https://doi.org/10.1161/CIRCULATIONAHA.110.949180.
Westerly BD, Johnson GB, Maldonado F, Utz JP, Specks U, Peikert T. Targeting B lymphocytes in progressive fibrosing mediastinitis. Am J Respir Crit Care Med. 2014;190(9):1069–71. https://doi.org/10.1164/rccm.201407-1258LE.
Myint T, Leedy N, Villacorta Cari E, Wheat LJ. HIV-Associated Histoplasmosis: Current Perspectives. HIV AIDS (Auckl). 2020;19(12):113–25. https://doi.org/10.2147/HIV.S185631.PMID:32256121;PMCID:PMC7090190.
Conces DJ Jr, Stockberger SM, Tarver RD, Wheat LJ. Disseminated histoplasmosis in AIDS: findings on chest radiographs. AJR Am J Roentgenol. 1993;160(1):15–9. https://doi.org/10.2214/ajr.160.1.8416614.
Ramos IC, Soares YC, Damasceno LS, Libório MP, Farias LABG, Heukelbach J, Alencar CHM, Leitão TDMJS. Predictive factors for disseminated histoplasmosis in AIDS patients with fever admitted to a reference hospital in Brazil. Rev Soc Bras Med Trop. 2018;51(4):479–84.
Agudelo CA, Restrepo CA, Molina DA, Tobón AM, Kauffman CA, Murillo C, Restrepo A. Tuberculosis and histoplasmosis co-infection in AIDS patients. Am J Trop Med Hyg. 2012. https://doi.org/10.4269/ajtmh.2012.12-0292.
Adenis A, Nacher M, Hanf M, Basurko C, Dufour J, Huber F, Aznar C, Carme B, Couppie P. Tuberculosis and histoplasmosis among human immunodeficiency virus-infected patients: a comparative study. Am J Trop Med Hyg. 2014;90(2):216–23. https://doi.org/10.4269/ajtmh.13-0084.
Caceres DH, Valdes A. Histoplasmosis and tuberculosis co-occurrence in people with advanced HIV. J Fungi (Basel). 2019;5(3):73. https://doi.org/10.3390/jof5030073.
Nacher M, Adenis A, Abboud P, Djossou F, Demar M, Epelboin L, Couppié P. HIV patients dying on anti-tuberculosis treatment: are undiagnosed infections still a problem in French Guiana? BMC Res Notes. 2020;13(1):209. https://doi.org/10.1186/s13104-020-05054-w.
Caceres DH, Tobón ÁM, Restrepo Á, Chiller T, Gómez BL. The important role of co-infections in patients with AIDS and progressive disseminated histoplasmosis (PDH): A cohort from Colombia. Med Mycol Case Rep. 2018;17(19):41–4. https://doi.org/10.1016/j.mmcr.2017.07.004.
Medina N, Alastruey-Izquierdo A, Bonilla O, Gamboa O, Mercado D, Pérez JC, Salazar LR, Arathoon E, Denning DW, Rodriguez-Tudela JL. A Rapid Screening Program for Histoplasmosis, Tuberculosis, and Cryptococcosis Reduces Mortality in HIV Patients from Guatemala. J Fungi. 2021. https://doi.org/10.3390/jof7040268.
Perez F, Caceres DH, Ford N, Ravasi G, Gomez BL, Pasqualotto AC, Hine P, Adenis AA, Nacher M, Chiller T, Baddley J. For The guideline development group for diagnosing and managing disseminated histoplasmosis among people living with hiv optional reference: summary of guidelines for managing histoplasmosis among people living with HIV. J Fungi (Basel). 2021;7(2):134.
Spec A, Connolly P, Montejano R, Wheat LJ. In vitro activity of isavuconazole against fluconazole-resistant isolates of Histoplasma capsulatum. Med Mycol. 2018;56(7):834–7.
Azar MM, Hage CA. Clinical perspectives in the diagnosis and management of histoplasmosis. Clin Chest Med. 2017;38(3):403–15. https://doi.org/10.1016/j.ccm.2017.04.004.
Hage CA, Azar MM, Bahr N, Loyd J, Wheat LJ. Histoplasmosis: Up-to-Date Evidence-Based Approach to Diagnosis and Management. Semin Respir Crit Care Med. 2015;36(5):729–45. https://doi.org/10.1055/s-0035-1562899.
Cáceres DH, Knuth M, Derado G, Lindsley MD. Diagnosis of progressive disseminated histoplasmosis in advanced HIV: A meta-analysis of assay analytical performance. J Fungi (Basel). 2019;5(3):76. https://doi.org/10.3390/jof5030076.PMID:31426618;PMCID:PMC6787751.
Miceli MH, Castillo CG, Kauffman CA. Diagnosis of midwestern endemic mycoses. Curr Fungal Infect Rep. 2016;10:87–95.
Richer SM, Smedema ML, Durkin MM, Herman KM, Hage CA, Fuller D, Wheat LJ. Improved diagnosis of acute pulmonary histoplasmosis by combining antigen and antibody detection. Clin Infect Dis. 2016;62(7):896–902.
de Almeida MA, Pizzini CV, Damasceno LS, Muniz Mde M, Almeida-Paes R, Peralta RH, Peralta JM, Oliveira Rde V, Vizzoni AG, de Andrade CL, Zancopé-Oliveira RM. Validation of western blot for Histoplasma capsulatum antibody detection assay. BMC Infect Dis. 2016. https://doi.org/10.1186/s12879-016-1427-0.
Almeida MA, Damasceno LS, Pizzini CV, Muniz MM, Almeida-Paes R, Zancopé-Oliveira RM. Role of western blot assay for the diagnosis of histoplasmosis in AIDS patients from a National Institute of Infectious Diseases in Rio de Janeiro. Brazil Mycoses. 2019;62(3):261–7. https://doi.org/10.1111/myc.12877.
Connolly PA, Durkin MM, Lemonte AM, Hackett EJ, Wheat LJ. Detection of histoplasma antigen by a quantitative enzyme immunoassay. Clin Vaccine Immunol. 2007. https://doi.org/10.1128/CVI.00071-07.
Hage CA, Ribes JA, Wengenack NL, Baddour LM, Assi M, McKinsey DS, Hammoud K, Alapat D, Babady NE, Parker M, Fuller D, Noor A, Davis TE, Rodgers M, Connolly PA, El Haddad B, Wheat LJ. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis. 2011;53(5):448–54. https://doi.org/10.1093/cid/cir435.
Wheat LJ. Approach to the diagnosis of the endemic mycoses. Clin Chest Med. 2009. https://doi.org/10.1016/j.ccm.2009.02.011.
Swartzentruber S, Rhodes L, Kurkjian K, Zahn M, Brandt ME, Connolly P, Wheat LJ. Diagnosis of acute pulmonary histoplasmosis by antigen detection. Clin Infect Dis. 2009;49(12):1878–82. https://doi.org/10.1086/648421.
Wheat J, Wheat H, Connolly P, Kleiman M, Supparatpinyo K, Nelson K, Bradsher R, Restrepo A. Cross-reactivity in Histoplasma capsulatum variety capsulatum antigen assays of urine samples from patients with endemic mycoses. Clin Infect Dis. 1997;24(6):1169–71. https://doi.org/10.1086/513647.
Cáceres DH, Samayoa BE, Medina NG, Tobón AM, Guzmán BJ, Mercado D, Restrepo A, Chiller T, Arathoon EE, Gómez BL. Multicenter validation of commercial antigenuria reagents to diagnose progressive disseminated histoplasmosis in people living with HIV/AIDS in Two Latin American Countries. J Clin Microbiol. 2018;56(6):e01959-e2017.
Samayoa B, Roy M, Cleveland AA, Medina N, Lau-Bonilla D, Scheel CM, Gomez BL, Chiller T, Arathoon E. High mortality and coinfection in a prospective cohort of human immunodeficiency virus/acquired immune deficiency syndrome patients with histoplasmosis in Guatemala. Am J Trop Med Hyg. 2017;97(1):42–8.
Cáceres DH, Zuluaga A, Arango-Bustamante K, de Bedout C, Tobón ÁM, Restrepo Á, Gómez BL, Cano LE, González Á. Implementation of a training course increased the diagnosis of histoplasmosis in Colombia. Am J Trop Med Hyg. 2015. https://doi.org/10.4269/ajtmh.15-0108.
Bansal N, Sethuraman N, Gopalakrishnan R, Ramasubramanian V, Kumar DS, Nambi PS, Chakrabarti A. Can urinary histoplasma antigen test improve the diagnosis of histoplasmosis in a tuberculosis endemic region? Mycoses. 2019;62(6):502–7. https://doi.org/10.1111/myc.12902.
Falci DR, Monteiro AA, Braz Caurio CF, Magalhães TCO, Xavier MO, Basso RP, Melo M, Schwarzbold AV, Ferreira PRA, Vidal JE, Marochi JP, Godoy CSM, Soares RBA, Paste A, Bay MB, Pereira-Chiccola VL, Damasceno LS, Leitão TDMJS, Pasqualotto AC. Histoplasmosis, an underdiagnosed disease affecting people living with HIV/AIDS in Brazil: results of a multicenter prospective cohort study using both classical mycology tests and histoplasma urine antigen detection. Open Forum Infect Dis. 2019;6(4):ofz073.
Cáceres DH, Gómez BL, Tobón AM, Chiller TM, Lindsley MD. Evaluation of a Histoplasma antigen lateral flow assay for the rapid diagnosis of progressive disseminated histoplasmosis in Colombian patients with AIDS. Mycoses. 2020;63(2):139–44. https://doi.org/10.1111/myc.13023.
Funding
The authors did not receive support from any organization for the submitted work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Tobón, A.M., Gómez, B.L. Pulmonary Histoplasmosis. Mycopathologia 186, 697–705 (2021). https://doi.org/10.1007/s11046-021-00588-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-021-00588-4